留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Potts分流术治疗顽固性肺动脉高压: 历史与展望

刘鑫裴 苗齐 刘剑州

刘鑫裴, 苗齐, 刘剑州. Potts分流术治疗顽固性肺动脉高压: 历史与展望[J]. 协和医学杂志, 2021, 12(3): 313-317. doi: 10.12290/xhyxzz.2021-0047
引用本文: 刘鑫裴, 苗齐, 刘剑州. Potts分流术治疗顽固性肺动脉高压: 历史与展望[J]. 协和医学杂志, 2021, 12(3): 313-317. doi: 10.12290/xhyxzz.2021-0047
LIU Xinpei, MIAO Qi, LIU Jianzhou. Potts Shunt for Refractory Pulmonary Hypertension: Historical and Future Perspectives[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 313-317. doi: 10.12290/xhyxzz.2021-0047
Citation: LIU Xinpei, MIAO Qi, LIU Jianzhou. Potts Shunt for Refractory Pulmonary Hypertension: Historical and Future Perspectives[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 313-317. doi: 10.12290/xhyxzz.2021-0047

Potts分流术治疗顽固性肺动脉高压: 历史与展望

doi: 10.12290/xhyxzz.2021-0047
详细信息
    通讯作者:

    苗齐  电话:010-69152829,E-mail: miaoqipumc@hotmail.com

  • 中图分类号: R541;R654.2

Potts Shunt for Refractory Pulmonary Hypertension: Historical and Future Perspectives

More Information
  • 摘要: 肺动脉高压是继发于先天性心脏病、肺血管病变、肺栓塞或因特发性疾病导致的以肺动脉压力升高为特点的疾病。充分靶向药物降压治疗下仍进展的顽固性肺动脉高压需手术干预,传统的肺移植或心肺联合移植手术面临供体有限、配型困难、免疫排斥等诸多问题。在此背景下,以建立心外体肺分流、缓解致命性右心衰竭为目的的Potts分流术逐渐复兴,但其用于治疗顽固性肺动脉高压的历史尚短,开展范围尚小,具体的适应证、禁忌证、手术策略及远期预后仍需更多循证医学证据支持。本文以Potts分流术的历史为线索,对该术式的优势、未来应用前景及尚未解决的关键问题进行论述。
    作者贡献:  作者贡献:刘鑫裴负责查阅文献、撰写论文; 苗齐负责选题设计、修订、审核论文; 刘剑州负责修订论文。
    利益冲突:   无
  • [1] Baruteau AE, Serraf A, Levy M, et al. Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results[J]. Ann Thorac Surg, 2012, 94: 817-824. doi:  10.1016/j.athoracsur.2012.03.099
    [2] D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry[J]. Ann Intern Med, 1991, 115: 343-349. doi:  10.7326/0003-4819-115-5-343
    [3] Rossano JW, Singh TP, Cherikh WS, et al. The Interna-tional Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report-2019; Focus theme: Donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38: 1028-1041. doi:  10.1016/j.healun.2019.08.002
    [4] Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. [J] Am J Cardiol, 1983, 51: 1560-1561. doi:  10.1016/0002-9149(83)90678-1
    [5] Cantor WJ, Harrison DA, Moussadji JS, et al. Deter-minants of survival and length of survival in adults with Eisenmenger syndrome[J]. Am J Cardiol, 1999, 84: 677-681. doi:  10.1016/S0002-9149(99)00415-4
    [6] Blanc J, Vouhe P, Bonnet D. Potts shunt in patients with pulmonary hypertension[J]. N Engl J Med, 2004, 350: 623. doi:  10.1056/NEJM200402053500623
    [7] Baruteau AE, Belli E, Boudjemline Y, et al. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients[J]. Eur J Cardiothorac Surg, 2015, 47: e105-e110. doi:  10.1093/ejcts/ezu445
    [8] Lancaster TS, Shahanavaz S, Balzer DT, et al. Midterm outcomes of the Potts shunt for pediatric pulmonary hyperten-sion, with comparison to lung transplant[J]. J Thorac Cardiovasc Surg, 2021, 161: 1139-1148. doi:  10.1016/j.jtcvs.2020.10.163
    [9] Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT[J]. J Heart Lung Transplant, 2019, 38: 879-901. doi:  10.1016/j.healun.2019.06.022
    [10] Thangappan K, Morales DLS. Commentary: To transplant or not to transplant: Potts shunt as an alternative to pediatric lung transplantation[J]. J Thorac Cardiovasc Surg, 2021, 161: 1149-1150. doi:  10.1016/j.jtcvs.2020.11.062
    [11] Grady RM, Eghtesady P. Potts Shunt and Pediatric Pulmonary Hypertension: What We Have Learned[J]. Ann Thorac Surg, 2016, 101: 1539-1543. doi:  10.1016/j.athoracsur.2015.08.068
    [12] Sabi TM, Schmitt B, Sigler M, et al. Transcatheter creation of an aortopulmonary shunt in an animal model[J]. Catheter Cardiovasc Interv, 2010, 75: 563-569. http://new.med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_JJ0217568038
    [13] Esch JJ, Shah PB, Cockrill BA, et al. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience[J]. J Heart Lung Transplant, 2013, 32: 381-387. doi:  10.1016/j.healun.2013.01.1049
    [14] Boudjemline Y, Patel M, Malekzadeh-Milani S, et al. Patent ductus arteriosus stenting (transcatheter Potts shunt) for palliation of suprasystemic pulmonary arterial hyperten-sion: a case series[J]. Circ Cardiovasc Interv, 2013, 6: e18-e20.
    [15] Boudjemline Y, Sizarov A, Malekzadeh-Milani S, et al. Safety and Feasibility of the Transcatheter Approach to Create a Reverse Potts Shunt in Children With Idiopathic Pulmonary Arterial Hypertension[J]. Can J Cardiol, 2017, 33: 1188-1196. doi:  10.1016/j.cjca.2017.06.004
    [16] Ratnayaka K, Rogers T, Schenke WH, et al. Magnetic Resonance Imaging-Guided Transcatheter Cavopulmonary Shunt[J]. JACC Cardiovasc Interv, 2016, 9: 959-970. doi:  10.1016/j.jcin.2016.01.032
    [17] Bui MT, Grollmus O, Ly M, et al. Surgical palliation of primary pulmonary arterial hypertension by a unidirectional valved Potts anastomosis in an animal model[J]. J Thorac Cardiovasc Surg, 2011, 142: 1223-1228. doi:  10.1016/j.jtcvs.2010.10.060
    [18] Rosenzweig EB, Ankola A, Krishnan U, et al. A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: Early experience in adolescents and adults[J]. J Thorac Cardiovasc Surg, 2021, 161: 1438-1446. e2. doi:  10.1016/j.jtcvs.2019.10.149
    [19] Garekar S, Meeran T, Dhake S, et al. Valved reverse Potts shunt in a case of pulmonary hypertension due to pulmonary veno-occlusive disease[J]. Indian J Thorac Cardiovasc Surg, 2021, 37: 89-92. doi:  10.1007/s12055-020-00993-2
  • 加载中
计量
  • 文章访问数:  1478
  • HTML全文浏览量:  357
  • PDF下载量:  166
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-01-14
  • 录用日期:  2021-03-23
  • 刊出日期:  2021-05-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!